Penny Stock Pick Report is pleased to alert investors of stocks on the move. Sign Up for our Stock Newsletter
MedLink International, Inc., recently announced the appointment of Scott D. Musch as Executive Vice President of Corporate Development. This newly created role includes responsibility for the company's corporate development activities, to include raising capital to fund corporate development, forging new relationships with investors, assisting in business development and corporate governance matters. Mr. Musch brings to MedLink 12 years of investment banking experience. Mr. Musch has earned an MBA with honors from the Tuck School of Business at
"We are pleased to expand our management team with an executive of this high caliber," said Ray Vuono, Chairman, CEO and President of MedLink. "We believe that Scott's extensive knowledge and experience in providing financial and strategic advisory services to healthcare services companies enhances our growth potential. His appointment strengthens our management team in key areas that are critical for our next stage of development."
Mr. Musch's appointment is effective immediately. He will be based at the company's corporate headquarters in
PennyStockPickReport About/Disclaimer
Sign Up for Penny Stock Pick Report’s Free Small Cap Newsletter! To subscribe please enter your email address in the frame at the bottom of this page or visit us at our website.
Subscribe at the bottom of this page.
About Us
Penny Stock Pick Report is a leading stock web site that provides free stock alerts on stocks that are poised to make big gains. We also track small cap companies that could be on the brink of a massive breakout. To feature a company on our web site please contact us at the email listed below.
Penny Stock Pick Report is an independent electronic publication that provides information on selected publicly traded companies. This publication is not a registered investment advisor or broker-dealer. Our affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above. View our full disclaimer.
